Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Li Li, Nan-Nan Chen, Qi-Dong You & Xiao-Li Xu. (2021) An updated patent review of anticancer Hsp90 inhibitors (2013-present). Expert Opinion on Therapeutic Patents 31:1, pages 67-80.
Read now
Read now
Tony Taldone, Hardik J Patel, Alexander Bolaender, Maulik R Patel & Gabriela Chiosis. (2014) Protein chaperones: a composition of matter review (2008 – 2013). Expert Opinion on Therapeutic Patents 24:5, pages 501-518.
Read now
Read now
Articles from other publishers (30)
Xiao-Nan Zhang, Ya Gao, Xi-Ya Zhang, Ning-Jie Guo, Wen-Qing Hou, Shu-Wu Wang, Yi-Chao Zheng, Ning Wang, Hong-Min Liu & Bo Wang. (2023) Detailed curriculum vitae of HER2-targeted therapy. Pharmacology & Therapeutics 245, pages 108417.
Crossref
Crossref
Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi & Nupur NagarKrishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi & Nupur Nagar. 2023. Protein-Protein Interactions. Protein-Protein Interactions
343
428
.
Enrique L. Larghi, Alexandre Bruneau, Félix Sauvage, Mouad Alami, Juliette Vergnaud-Gauduchon & Samir Messaoudi. (2022) Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1H)-ones Bis-Heterocycles as Potential Inhibitors of the Protein Folding Machinery Hsp90. Molecules 27:2, pages 412.
Crossref
Crossref
Hongbin Guo, Baohua Chen, Zihan Yan, Jian Gao, Jiamei Tang & Chengyan Zhou. (2020) Metabolites profiling and pharmacokinetics of troxipide and its pharmacodynamics in rats with gastric ulcer. Scientific Reports 10:1.
Crossref
Crossref
Yanping Tang, Kezhi Li, Zhengmin Cai, Yuxuan Xie, Xiaoyu Tan, Chenglin Su & Jilin Li. (2020) HSP90α combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma. Biomarkers in Medicine 14:10, pages 869-878.
Crossref
Crossref
Hao Chen, Yuanying Gong, Yufang Ma, Reid C. Thompson, Jialiang Wang, Zhixiang Cheng & Lixia Xue. (2020) A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation. Frontiers in Pharmacology 11.
Crossref
Crossref
Tony Taldone, Tai Wang, Anna Rodina, Naga Vara Kishore Pillarsetty, Chander S. Digwal, Sahil Sharma, Pengrong Yan, Suhasini Joshi, Piyusha P. Pagare, Alexander Bolaender, Gail J. Roboz, Monica L. Guzman & Gabriela Chiosis. (2020) A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond. Cold Spring Harbor Perspectives in Biology 12:4, pages a034116.
Crossref
Crossref
Suman Chatterjee & Timothy F. Burns. 2019. Heat Shock Proteins in Signaling Pathways. Heat Shock Proteins in Signaling Pathways
359
395
.
Alexandra Canonici, Zulfiqar Qadir, Neil T. Conlon, Denis M. Collins, Neil A. O’Brien, Naomi Walsh, Alex J. Eustace, Norma O’Donovan & John Crown. (2018) The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells. Investigational New Drugs 36:4, pages 581-589.
Crossref
Crossref
Anuj Khandelwal, Vincent M. Crowley & Brian S. J. Blagg. (2015) Natural Product Inspired N‐Terminal Hsp90 Inhibitors: From Bench to Bedside?. Medicinal Research Reviews 36:1, pages 92-118.
Crossref
Crossref
Sirintip Boonjaraspinyo, Amornrat Juasook, Thidarut Boonmars, Ratchadawan Aukkanimart, Atit Silsirivanit, Watcharin Loilome, Pranee Sriraj, Zhiliang Wu & Panaratana Ratanasuwan. (2015) A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention 16:14, pages 5779-5785.
Crossref
Crossref
H Liu, J Lu, Y Hua, P Zhang, Z Liang, L Ruan, C Lian, H Shi, K Chen & Z Tu. (2015) Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer. Cell Death & Disease 6:1, pages e1595-e1595.
Crossref
Crossref
Pierfausto Seneci. 2015. Chemical Modulators of Protein Misfolding and Neurodegenerative Disease. Chemical Modulators of Protein Misfolding and Neurodegenerative Disease
25
71
.
Tao Meng, Dadong Zhang, Zuoquan Xie, Ting Yu, Shuchao Wu, Lorenza Wyder, Urs Regenass, Kurt Hilpert, Min Huang, Meiyu Geng & Jingkang Shen. (2014) Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90. Journal of Medicinal Chemistry 57:23, pages 9832-9843.
Crossref
Crossref
Zuzana Sol�rov�, J�n Mojžiš & Peter Sol�r. (2014) Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review). International Journal of Oncology.
Crossref
Crossref
Davide Audisio, Délphine Methy-Gonnot, Christine Radanyi, Jack-Michel Renoir, Stéphanie Denis, Félix Sauvage, Juliette Vergnaud-Gauduchon, Jean-Daniel Brion, Samir Messaoudi & Mouad Alami. (2014) Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors. European Journal of Medicinal Chemistry 83, pages 498-507.
Crossref
Crossref
Jonathan W Goldman, Robert N Raju, Gregory A Gordon, Iman El-Hariry, Florentina Teofilivici, Vojo M Vukovic, Robert Bradley, Michael D Karol, Yu Chen, Wei Guo, Takayo Inoue & Lee S Rosen. (2013) A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies. BMC Cancer 13:1.
Crossref
Crossref
Naomi Ono, Toshikazu Yamazaki, Toshiyuki Tsukaguchi, Toshihiko Fujii, Kiyoaki Sakata, Atsushi Suda, Takuo Tsukuda, Toshiyuki Mio, Nobuya Ishii, Osamu Kondoh & Yuko Aoki. (2013) Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer. Cancer Science 104:10, pages 1346-1352.
Crossref
Crossref
Yilin Zhao, Zheng-Jie Huang, Milladur Rahman, Qi Luo & Henrik Thorlacius. (2013) Radicicol, an Hsp90 inhibitor, inhibits intestinal inflammation and leakage in abdominal sepsis. Journal of Surgical Research 182:2, pages 312-318.
Crossref
Crossref
Samir Messaoudi, Marie Gabillet, Jean-Daniel Brion & Mouâd Alami. (2013)
An efficient synthesis of 3-triazolyl-2(1
H
)-quinolones by CuTC-catalyzed azide-alkyne cycloaddition reaction
. Applied Organometallic Chemistry 27:3, pages 155-158.
Crossref
Crossref
Fengzhi Li. 2013.
217
252
.
Cheng-Zhu Wu, Jae-Hyuk Jang, Mihee Woo, Jong Seog Ahn, Joong Su Kim & Young-Soo Hong. (2012) Enzymatic Glycosylation of Nonbenzoquinone Geldanamycin Analogs via Bacillus UDP-Glycosyltransferase. Applied and Environmental Microbiology 78:21, pages 7680-7686.
Crossref
Crossref
Alberto Bargiotti, Loana Musso, Sabrina Dallavalle, Lucio Merlini, Grazia Gallo, Andrea Ciacci, Giuseppe Giannini, Walter Cabri, Sergio Penco, Loredana Vesci, Massimo Castorina, Ferdinando Maria Milazzo, Maria Luisa Cervoni, Marcella Barbarino, Claudio Pisano, Chiara Giommarelli, Valentina Zuco, Michelandrea De Cesare & Franco Zunino. (2012) Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors. European Journal of Medicinal Chemistry 53, pages 64-75.
Crossref
Crossref
Hans-Peter Buchstaller, Hans-Michael Eggenweiler, Christian Sirrenberg, Ulrich Grädler, Djordje Musil, Edmund Hoppe, Astrid Zimmermann, Harry Schwartz, Joachim März, Jörg Bomke, Ansgar Wegener & Michael Wolf. (2012) Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90. Bioorganic & Medicinal Chemistry Letters 22:13, pages 4396-4403.
Crossref
Crossref
Davide Audisio, Samir Messaoudi, Sandrine Cojean, Jean-François Peyrat, Jean-Daniel Brion, Christian Bories, Françoise Huteau, Philippe M. Loiseau & Mouad Alami. (2012) Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives. European Journal of Medicinal Chemistry 52, pages 44-50.
Crossref
Crossref
Nuri Kim, Jong Youl Kim & Midori A. Yenari. (2012) Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury. Inflammopharmacology 20:3, pages 177-185.
Crossref
Crossref
Samir Messaoudi, Jean-Daniel Brion & Mouad Alami. (2012) Palladium-Catalyzed Decarboxylative Coupling of Quinolinone-3-Carboxylic Acids and Related Heterocyclic Carboxylic Acids with (Hetero)aryl Halides. Organic Letters 14:6, pages 1496-1499.
Crossref
Crossref
Jon Travers, Swee Sharp & Paul Workman. (2012) HSP90 inhibition: two-pronged exploitation of cancer dependencies. Drug Discovery Today 17:5-6, pages 242-252.
Crossref
Crossref
Len Neckers & Paul Workman. (2012) Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?. Clinical Cancer Research 18:1, pages 64-76.
Crossref
Crossref
Frank Wuest, Vincent Bouvet, BaoChan Mai & Paul LaPointe. (2012) Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90. Organic & Biomolecular Chemistry 10:33, pages 6724.
Crossref
Crossref